[Molecular pathological diagnosis of soft tissue tumors]

Tadashi Hasegawa1

  • 1Department of Surgical Pathology, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan. hasetada@sapmed.ac.jp

Rinsho Byori. the Japanese Journal of Clinical Pathology
|May 26, 2010
PubMed

Insights

Accurate diagnosis of soft tissue tumors is improved by detecting specific fusion genes using split-signal DNA probes for fluorescence in situ hybridization (FISH) analysis. This method aids routine pathological diagnosis of challenging tumor types.

Area of Science:

  • Oncology
  • Genetics
  • Pathology

Context:

  • Soft tissue tumors present diagnostic and therapeutic challenges.
  • Specific chromosomal abnormalities, including translocations and fusion genes, are characteristic of these tumors.
  • Accurate detection of these genetic alterations is crucial for diagnosis.

Purpose:

  • To develop and apply split-signal DNA probes for fluorescence in situ hybridization (FISH) analysis.
  • To detect specific fusion genes in soft tissue tumors for accurate diagnosis.
  • To integrate FISH analysis into routine pathological diagnosis.

Summary:

  • This study focuses on developing split-signal DNA probes for FISH analysis to detect fusion genes in soft tissue tumors.
  • FISH analysis is performed on formalin-fixed, paraffin-embedded histological specimens.
  • The article details the principles of detecting fusion genes via RT-PCR and FISH, outlines FISH procedures with split-signal probes, and presents results for Ewing sarcoma/PNET, rhabdomyosarcoma, pleomorphic liposarcoma, and extraskeletal myxoid chondrosarcoma.

Impact:

  • Enables more accurate and reliable pathological diagnosis of soft tissue tumors.
  • Facilitates the identification of specific genetic markers for targeted therapies.
  • Contributes to improved patient management and treatment strategies for soft tissue malignancies.

Related Concept Videos